Login
 Forum
 
 
Personal data sheet
 Print preview
personal data approved: 2021. III. 04.
Personal data
András Inotai
name András Inotai
year of birth 1984
name of institution
doctoral school
SE Doctoral School of Pharmaceutical Sciences (Supervisor)
Contact details
own web page
Academic title
scientific degree, title Ph.D.
year degree was obtained 2011
discipline to which degree belongs pharmaceutics
institution granting the degree Semmelweis University
scientific degree, title Habilitation
year degree was obtained 2018
discipline to which degree belongs sociology
institution granting the degree Eötvös Loránd University
Employment
2019 - Semmelweis University, Budapest
university professor or researcher
2009 - Syreon Kutató Intézet
other (not specified) (vezető kutató)
Thesis topic supervisor
number of doctoral students supervised until now 2
number of students who fulfilled course requirements 0.5
students who obtained their degrees:
students with degree granting in process:
(50%) András Harsányi PhD (2022/08)  DSoS
present PhD students:
Dalma Erdősi (PhD) (2024/08)  DSPS1-SE
(50%) Zsuzsanna Ida Petykó (PhD) (2023/01)  DSPS1-SE
  Thesis topic proposals
Research
research area health economics, pharmacoeconomics, pharmaceutical policy
research field in which current research is conducted general health sciences
Publications
2020

Inotai Andras, Tomek Dominik, Niewada Maciej, Lorenzovici Laszlo, Kolek Martin, Weber Jakub, Kurrat Anne-Katrin, Kiss Emese Virag, Kalo Zoltan: Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries, FRONTIERS IN PHARMACOLOGY 11: 845
type of document: Journal paper/Article
language: English
URL 
2019

Inotai András, Ágh Tamás, Karpenko Alexei Willem, Zemplényi Antal, Kaló Zoltán: Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries, EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH 19: (2) pp. 105-113.
type of document: Journal paper/Article
language: English
URL 
2019

Harsányi András, Csanádi Marcell, Márky Kristóf, Vincziczki Áron Zoltán, Kaló Zoltán, Inotai András: Influence of biosimilar infliximab launch on the utilization pattern of biological medicines : the case of Hungary, EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH 2019:
type of document: Journal paper/Article
language: English
URL 
2018

Inotai A, Csanadi M, Petrova G, Dimitrova M, Bochenek T, Tesar T, York K, Fuksa L, Kostyuk A, Lorenzovici L, Omelyanovskiy V, Egyed K, Kalo Z: Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts., BIOMED RESEARCH INTERNATIONAL (2018) 9597362
type of document: Journal paper/Article
number of independent citations: 6
language: English
URL 
2018

Inotai A, Nguyen HT, Hidayat B, Nurgozhin T, Kiet PHT, Campbell JD, Nemeth B, Maniadakis N, Brixner D, Wijaya K, Kalo Z: Guidance toward the implementation of multicriteria decision analysis framework in developing countries, EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH 18: (6) pp. 585-592.
type of document: Journal paper/Review paper
number of independent citations: 7
language: English
URL 
2018

Tomasz Bochenek, Vafa Abilova, Ali Alkan, Bogdan Asanin, Iñigo de Miguel Beriain, Zeljka Besovic, Patricia Vella Bonanno, Anna Bucsics, Michal Davidescu, Elfi De Weerdt, Natasa Duborija-Kovacevic, Jurij Fürst, Mina Gaga, Elma Gailīte, Jolanta Gulbinovič, Emre Umut Gürpınar, Balázs Hankó, Vincent Hargaden, Tor Arne Hotvedt, Iris Hoxha, Isabelle Huys, Andras Inotai, Arianit Jakupi, Helena Jenzer, Roberta Joppi, Ott Laius, Marie-Camille Lenormand, Despina Makridaki, Admir Malaj, Kertu Margus, Vanda Marković-Peković, Nenad Miljković, João Luís de Miranda, Stanislav Primožič, Dragana Rajinac, David G Schwartz, Robin Šebesta, Steven Simoens, Juraj Slaby, Ljiljana Sović-Brkičić, Tomas Tesar, Leonidas Tzimis, Ewa Warmińska, Brian Godman: Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries, FRONTIERS IN PHARMACOLOGY 8: 942
type of document:
number of independent citations: 9
language: English
URL 
2017

Inotai A, Prins CPJ, Csanádi M, Vitezic D, Codreanu C, Kaló Z: Is there a reason for concern or is it just hype?–A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars, EXPERT OPINION ON BIOLOGICAL THERAPY 17: (8) pp. 915-926.
type of document: Journal paper/Review paper
number of independent citations: 21
language: English
URL 
2014

Inotai A, Petrova G, Vitezic D, Kalo Z: Benefits of investment into modern medicines in Central-Eastern European countries., EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH 14: (1) pp. 71-79.
type of document: Journal paper/Review paper
language: English
URL 
2012

Inotai Andras, Pekli Marta, Jona Gabriella, Nagy Orsolya, Remak Edit, Kalo Zoltan: Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology, BMC HEALTH SERVICES RESEARCH 12: (1) 332
type of document: Journal paper/Article
number of independent citations: 8
language: English
URL 
2011

Ágh T, Inotai A, Mészáros Á: Factors associated with medication adherence in patients with chronic obstructive pulmonary disease, RESPIRATION 82: (4) pp. 328-334.
type of document: Journal paper/Article
number of independent citations: 87
language: English
URL 
Number of independent citations to these publications:138 
Scientometric data
list of publications and citations
number of scientific publications that meet accreditation criteria:
90
number of scientific publications:
90
monographs and professional books:
3
monographs/books in which chapters/sections were contributed:
4 
number of independent citations to scientific publications and creative works:
391


2021. V. 01.
ODT online ülés
Az ODT következő, online ülésére 2021. május 21-én 10.00 órakor kerül sor.

 
All rights reserved © 2007, Hungarian Doctoral Council. Doctoral Council registration number at commissioner for data protection: 02003/0001. Program version: 2.2358 ( 2017. X. 31. )